Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    RADx COVID-19 Testing Proposals Advance into Phase II

    Article obtained from BioPhotonics RSS Feed.

    The National Institutes of Health’s (NIH) Rapid Acceleration of Diagnostics (RADx) program has inked seven contracts, totaling nearly $250 million in combined funding, in its effort to expand COVID-19 testing capabilities. The RADx program was launched by NIH’s National Institute of Biomedical Imaging and Bioengineering in April, following Congress’ $500 million appropriation for testing and a “national COVID-19 testing challenge” announced by the NIH.

    The program has received more than 650 project proposals and has so far narrowed its potential list of award recipients to 100 and, ultimately, seven awardees. Those proposals and their projects have now entered “Phase 2” funding, as the NIH…

    READ MORE
    Aug, 06 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.